| |
|
|
|
Therapix Biosciences Ltd.  
|
|
3.77 -0.13 (-0.03%) |
01-15 16:00 |
|
Open: |
3.9173 |
Pre close: |
3.9 |
Target:
|
5.17 
|
|
High: |
4.025 |
Low: |
3.75 |
Resistance:
|
4.43
5.30
|
|
Volume: |
18,720 |
Market Cap: |
13M |
Support:
|
3.01
2.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.82
 |
MACD |
MACD(12,26):
|
-0.41 |
|
MA(20): |
3.77 |
Signal(12,26,9): |
-0.54 |
|
MA(100): |
5.16 |
Stochastic Oscillator |
%K(14,3):
|
54.30 |
|
MA(250): |
4.89 |
%D(3): |
50.17 |
|
Average Volume(K) |
3-Month: |
17829
|
52-Week |
High:
|
9.30 |
|
10-Days: |
6091 |
Low: |
3.00 |
|
RSI |
RSI(14):
|
40.55 |
Change(%): |
-37.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-114.0 |
Shares Out. (M) |
3.50 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
-96.8 |
Shares Float (M) |
3.50 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.30 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.930 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.96 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.84 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.80 |
P/CF |
-2.26 |
|
|
|
|
|
|
